FIELD: organic chemistry, medicine, pharmacy.
SUBSTANCE: invention relates to derivatives of imidazole of the formula (I):
or its pharmaceutically acceptable salts wherein X represents -CH2-(CH2)p-, -O-; R1 represents phenyl, naphthyl, 1,2,3,4-tetrahydronaphthyl, (C3-C7)-cycloalkyl wherein indicated phenyl, naphthyl, 1,2,3,4-tetrahydronaphthyl, (C3-C7)-cycloalkyl are substituted optionally with 1-3 substitutes taken independently among halogen atom, -OH, halogen-(C1-C6)-alkyl, (C1-C6)-alkyl, (C1-C6)-alkoxy group and OH-(C1-C6)-alkyl; R2 represents hydrogen atom (H) or (C1-C6)-alkyl; R3 represents H or (C1-C6)-alkyl; R4 represents H or (C1-C6)-alkyl; R5 represents H, or R5 and R7 form in common a bond; each R6 represents independently halogen atom, -OH, halogen-(C1-C6)-alkyl, (C1-C6)-alkyl, (C1-C6)-alkoxy group or OH-(C1-C6)-alkyl; R7 represents H, or R7 and R5 form in common a bond; each R8 represents independently -OH, (C1-C6)-alkyl, halogen-(C1-C6)-alkyl or (C1-C6)-alkoxy group; m = 0, 1, 2 or 3; n = 0 or 1; p = 0 or 1; r = 0 or 1; t = 0. Also, invention relates to a method for preparing compounds of the formula (I) and to a pharmaceutical composition showing affinity to alpha-2-adrenoceptors based on these compounds. Invention provides preparing new compounds and pharmaceutical composition based on thereof used in aims for treatment of neurological disturbances, psychiatric disorders or disturbances in cognitive ability, diabetes mellitus, lipolytic diseases, orthostatic hypotension or sexual dysfunction.
EFFECT: improved preparing method, valuable medicinal properties of compounds and compositions.
25 cl, 1 tbl, 14 ex
| Title | Year | Author | Number |
|---|---|---|---|
| 2-THIO SUBSTITUTED DERIVATIVES OF IMIDAZOLE AND THEIR USE IN PHARMACEUTICALS | 2003 |
|
RU2331638C2 |
| SULFONYL UREA AND RELATED COMPOUNDS AND USE THEREOF | 2016 |
|
RU2739356C2 |
| 2-AMINOPYRIDINE DERIVATIVES, PHARMACEUTICAL COMPOSITION CONTAINING THE SAME AND METHOD FOR THERAPY | 2001 |
|
RU2250898C2 |
| QUINUCLIDINE COMPOUNDS, MEDICINAL AGENTS COMPRISING THEREOF AND METHODS FOR PREPARING QUINUCLIDINE COMPOUNDS | 2000 |
|
RU2266905C2 |
| SULPHONYLUREAS AND RELATED COMPOUNDS AND THEIR USE | 2016 |
|
RU2795512C2 |
| SUBSTITUTED 4-(AZOL-1-YLMETHYL)-1-PHENYL-5,5-DIALKYL-SPIRO-[2.5]OCTAN-4-OLS, METHOD FOR PRODUCTION THEREOF (VERSIONS), FUNGICIDAL AND GROWTH-REGULATING COMPOSITION BASED THEREON | 2016 |
|
RU2648240C1 |
| N3-SUBSTITUTED N1-SULPHONYL-5-FLUOROPYRIMIDINE DERIVATIVE, COMPOSITION BASED THEREON AND LEAF SPOT PREVENTION | 2011 |
|
RU2562840C2 |
| ENANTIOMERICALLY PURE BASIC ARYLCYCLOALKYLHYDROXYCARBOXYLIC ACID ESTERS, METHOD FOR THEIR PREPARING AND APPLYING IN MEDICINAL AGENTS | 1997 |
|
RU2238936C2 |
| SUBSTITUTED EMIDAZOLES, METHODS OF PREPARATION THEREOF, PHARMACEUTICAL COMPOSITION BASED THEREON, AND METHOD OF MEDICAL TREATMENT | 1992 |
|
RU2120440C1 |
| 1,2,4-TRIAZOLE DERIVATIVES AS SIGMA RECEPTOR INHBITORS | 2007 |
|
RU2451015C2 |
